Benign Metastasizing Leiomyoma of the Uterus: Rare Manifestation of a Frequent Pathology

<div>Cytogenetic study of BML and uterine leiomyoma of patient 2, using “<i>Fluorescence In Situ Hybridization” (FISH), </i>with probes<i> LSI EWSR1 (22q12) Dual Color, Break Apart Rearrangement Probe, Abbott</i>, and<i> ZytoLight SPEC 19q13/19q13 Dual Color Probe, Zytovision. (a) </i>22q12 deletion and (b) 19q13 deletion.</div>

Case Reports in Obstetrics and Gynecology

fig5

Figure 5

Figure 5: Benign Metastasizing Leiomyoma of the Uterus: Rare Manifestation of a Frequent Pathology 